Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000180776 | SCV000256756 | pathogenic | Autoimmune interstitial lung disease-arthritis syndrome | 2015-04-20 | criteria provided, single submitter | research | Segregates with the phenotype in two affected families. One family showed incomplete penetrance, with one unaffected carrier over four generations. |
Invitae | RCV000180776 | SCV000774975 | pathogenic | Autoimmune interstitial lung disease-arthritis syndrome | 2023-12-10 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 233 of the COPA protein (p.Arg233His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autoimmune-mediated lung disease and arthritis (PMID: 25894502). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 199254). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COPA protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects COPA function (PMID: 25894502). For these reasons, this variant has been classified as Pathogenic. |
Clinical Molecular Genetics Laboratory, |
RCV000180776 | SCV000930528 | pathogenic | Autoimmune interstitial lung disease-arthritis syndrome | 2019-08-01 | criteria provided, single submitter | clinical testing | identified in different affected members of same family |
Baylor Genetics | RCV000180776 | SCV001530127 | pathogenic | Autoimmune interstitial lung disease-arthritis syndrome | 2018-05-07 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease causing in multiple individuals from two unrelated families with autoimmune disease and functional studies showed that this mutation causes increased ER stress [PMID 25894502, 27577878] |
Center for Personalized Medicine, |
RCV003156081 | SCV003845270 | pathogenic | See cases | 2022-12-21 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000180776 | SCV000233264 | pathogenic | Autoimmune interstitial lung disease-arthritis syndrome | 2015-06-01 | no assertion criteria provided | literature only |